These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4588603)

  • 1. The prognostic significance of delayed cutaneous reactivity in head and neck cancer patients.
    Mandel MA; Kiehn CL
    Plast Reconstr Surg; 1974 Jan; 53(1):72-6. PubMed ID: 4588603
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous reactivity in patients with cancer of the head and neck region.
    Mandel MA; Kiehn C
    Surg Forum; 1973; 24():534-5. PubMed ID: 4806088
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 8. The delayed hypersensitivity reaction in cancer patient: observations on sensitization by DNCB.
    Chakravorty RC; Curutchet HP; Coppolla FS; Park CM; Blaylock WK; Lawrence W
    Surgery; 1973 May; 73(5):730-5. PubMed ID: 4697093
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed hypersensitivity in alcoholic cirrhosis.
    Scheinberg MA
    Am J Dig Dis; 1972 Aug; 17(8):760. PubMed ID: 5046738
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin testing for prognosis or therapy formulation in cancer patients: caveat emptor.
    Mandel MA
    Plast Reconstr Surg; 1976 May; 57(5):621-6. PubMed ID: 1273144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ; Chretien PB
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo anergy reversal with cimetidine in patients with cancer.
    Richtsmeier WJ; Eisele D
    Arch Otolaryngol Head Neck Surg; 1986 Oct; 112(10):1074-7. PubMed ID: 3755977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor spread and reactivity to DNCB: (2, 4 Dinitro-1 chlorobenzene) skin test.
    el-Domeiri AA
    Int Surg; 1972 Aug; 57(8):617-9. PubMed ID: 5051760
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
    Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
    Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response?
    Johnson MW; Maibach HI; Salmon SE
    N Engl J Med; 1971 Jun; 284(22):1255-7. PubMed ID: 5573838
    [No Abstract]   [Full Text] [Related]  

  • 16. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
    Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
    J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
    Bier J; Nicklisch U
    Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 19. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB; Twomey PL; Trahan EE; Catalona WJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.